BACKGROUND: Malaria during pregnancy is associated with low birth weight and increased perinatal mortality, especially among primigravidae. Despite increasing prevalence of malarial parasite resistance to sulfadoxine-pyrimethamine (SP), SP continues to be recommended for intermittent preventive treatment in pregnancy (IPTp). METHODS: Women without human immunodeficiency virus infection were enrolled upon delivery. Data on the number of SP doses received during pregnancy were recorded. The primary outcome was placental infection demonstrated by histologic analysis. Secondary outcomes included malaria parasitemia (in peripheral, placental, cord blood specimens) at delivery and composite birth outcome (small for gestational age, preterm delivery, or low birth weight). RESULTS.: Of 703 women enrolled, 22% received <2 SP doses. Receipt of ≥ 2 SP doses had no impact on histologically confirmed placental infection. IPTp-SP was associated with a dose-dependent protective effect on composite birth outcome in primigravidae, with an adjusted prevalence ratio of 0.50 (95% confidence interval [CI], .30-.82), 0.30 (95% CI, .19-.48), and 0.18 (95% CI, .05-.61) for 1, 2, and ≥ 3 doses, respectively, compared with 0 doses. CONCLUSIONS: IPTp-SP did not reduce the frequency of placental infection but was associated with improved birth outcomes. Few women received no SP, so the true effect of IPTp-SP may be underestimated. Malawian pregnant women should continue to receive IPTp-SP, but alternative strategies and antimalarials for preventing malaria during pregnancy should be investigated.
BACKGROUND:Malaria during pregnancy is associated with low birth weight and increased perinatal mortality, especially among primigravidae. Despite increasing prevalence of malarial parasite resistance to sulfadoxine-pyrimethamine (SP), SP continues to be recommended for intermittent preventive treatment in pregnancy (IPTp). METHODS:Women without human immunodeficiency virus infection were enrolled upon delivery. Data on the number of SP doses received during pregnancy were recorded. The primary outcome was placental infection demonstrated by histologic analysis. Secondary outcomes included malaria parasitemia (in peripheral, placental, cord blood specimens) at delivery and composite birth outcome (small for gestational age, preterm delivery, or low birth weight). RESULTS.: Of 703 women enrolled, 22% received <2 SP doses. Receipt of ≥ 2 SP doses had no impact on histologically confirmed placental infection. IPTp-SP was associated with a dose-dependent protective effect on composite birth outcome in primigravidae, with an adjusted prevalence ratio of 0.50 (95% confidence interval [CI], .30-.82), 0.30 (95% CI, .19-.48), and 0.18 (95% CI, .05-.61) for 1, 2, and ≥ 3 doses, respectively, compared with 0 doses. CONCLUSIONS:IPTp-SP did not reduce the frequency of placental infection but was associated with improved birth outcomes. Few women received no SP, so the true effect of IPTp-SP may be underestimated. Malawian pregnant women should continue to receive IPTp-SP, but alternative strategies and antimalarials for preventing malaria during pregnancy should be investigated.
Authors: M E Parise; J G Ayisi; B L Nahlen; L J Schultz; J M Roberts; A Misore; R Muga; A J Oloo; R W Steketee Journal: Am J Trop Med Hyg Date: 1998-11 Impact factor: 2.345
Authors: Stephen J Rogerson; Elena Pollina; Abera Getachew; Eyob Tadesse; Valentino M Lema; Malcolm E Molyneux Journal: Am J Trop Med Hyg Date: 2003-01 Impact factor: 2.345
Authors: B Bwijo; A Kaneko; M Takechi; I L Zungu; Y Moriyama; J K Lum; T Tsukahara; T Mita; N Takahashi; Y Bergqvist; A Björkman; T Kobayakawa Journal: Acta Trop Date: 2003-03 Impact factor: 3.112
Authors: Julie Gutman; Linda Kalilani; Steve Taylor; Zhiyong Zhou; Ryan E Wiegand; Kyaw L Thwai; Dyson Mwandama; Carole Khairallah; Mwayi Madanitsa; Ebbie Chaluluka; Fraction Dzinjalamala; Doreen Ali; Don P Mathanga; Jacek Skarbinski; Ya Ping Shi; Steve Meshnick; Feiko O ter Kuile Journal: J Infect Dis Date: 2015-01-06 Impact factor: 5.226
Authors: Abel Kakuru; Prasanna Jagannathan; Mary K Muhindo; Paul Natureeba; Patricia Awori; Miriam Nakalembe; Bishop Opira; Peter Olwoch; John Ategeka; Patience Nayebare; Tamara D Clark; Margaret E Feeney; Edwin D Charlebois; Gabrielle Rizzuto; Atis Muehlenbachs; Diane V Havlir; Moses R Kamya; Grant Dorsey Journal: N Engl J Med Date: 2016-03-10 Impact factor: 91.245
Authors: Verner N Orish; Onyekachi S Onyeabor; Johnson N Boampong; Richmond Afoakwah; Ekene Nwaefuna; Samuel Acquah; Adekunle O Sanyaolu; Nnaemeka C Iriemenam Journal: Afr Health Sci Date: 2015-12 Impact factor: 0.927
Authors: Melissa D Conrad; Daniel Mota; Marissa Foster; Stephen Tukwasibwe; Jennifer Legac; Patrick Tumwebaze; Meghan Whalen; Abel Kakuru; Patience Nayebare; Erika Wallender; Diane V Havlir; Prasanna Jagannathan; Liusheng Huang; Francesca Aweeka; Moses R Kamya; Grant Dorsey; Philip J Rosenthal Journal: J Infect Dis Date: 2017-11-15 Impact factor: 5.226
Authors: Meghna Desai; Julie Gutman; Steve M Taylor; Ryan E Wiegand; Carole Khairallah; Kassoum Kayentao; Peter Ouma; Sheick O Coulibaly; Linda Kalilani; Kimberly E Mace; Emmanuel Arinaitwe; Don P Mathanga; Ogobara Doumbo; Kephas Otieno; Dabira Edgar; Ebbie Chaluluka; Mulakwa Kamuliwo; Veronica Ades; Jacek Skarbinski; Ya Ping Shi; Pascal Magnussen; Steve Meshnick; Feiko O Ter Kuile Journal: Clin Infect Dis Date: 2015-10-20 Impact factor: 9.079
Authors: Kimberly E Mace; Victor Chalwe; Bonnie L Katalenich; Michael Nambozi; Luamba Mubikayi; Chikuli K Mulele; Ryan E Wiegand; Scott J Filler; Mulakwa Kamuliwo; Allen S Craig; Kathrine R Tan Journal: Malar J Date: 2015-02-07 Impact factor: 2.979
Authors: Liana R Andronescu; Ankur Sharma; Ingrid Peterson; Martin Kachingwe; Witness Kachepa; Yuanyuan Liang; Julie R Gutman; Don P Mathanga; Jobiba Chinkhumba; Miriam K Laufer Journal: J Infect Dis Date: 2022-01-18 Impact factor: 7.759
Authors: Harry Tagbor; Matthew Cairns; Kalifa Bojang; Sheick Oumar Coulibaly; Kassoum Kayentao; John Williams; Ismaela Abubakar; Francis Akor; Khalifa Mohammed; Richard Bationo; Edgar Dabira; Alamissa Soulama; Moussa Djimdé; Etienne Guirou; Timothy Awine; Stephen Quaye; Fanta Njie; Jaume Ordi; Ogobara Doumbo; Abraham Hodgson; Abraham Oduro; Steven Meshnick; Steve Taylor; Pascal Magnussen; Feiko ter Kuile; Arouna Woukeu; Paul Milligan; Daniel Chandramohan; Brian Greenwood Journal: PLoS One Date: 2015-08-10 Impact factor: 3.240